| Income Statement |
| Total Revenue | 43.42M |
|
| Revenues (USD) | 43.42M |
| Cost of Revenue | 65.36M |
| Gross Profit | -21.94M |
| Operating Expenses | 44.17M |
| Research and Development Expense | 55.00K |
| Selling, General and Administrative Expense | 44.12M |
| Operating Income | -66.11M |
| Net Income | -166.22M |
| Net Income Common Stock | -166.22M |
| Net Income Common Stock (USD) | -166.22M |
| Consolidated Income | -166.22M |
| Earning Before Interest & Taxes (EBIT) | -166.22M |
| Earning Before Interest & Taxes (USD) | -166.22M |
| Weighted Average Shares | 263.97M |
| Balance Sheet |
| Cash and Equivalents | 228.29M |
| Cash and Equivalents (USD) | 228.29M |
| Investments | 719.95M |
| Investments Current | 449.51M |
| Investments Non-Current | 270.44M |
| Trade and Non-Trade Receivables | 77.30M |
| Current Assets | 774.38M |
| Property, Plant & Equipment Net | 96.85M |
| Total Assets | 1.20B |
| Total Debt | 24.79M |
| Current Liabilities | 89.35M |
| Debt Non-Current | 24.79M |
| Total Liabilities | 150.08M |
| Accumulated Retained Earnings (Deficit) | -1.40B |
| Accumulated Other Comprehensive Income | 26.00K |
| Shareholders Equity | -1.39B |
| Shareholders Equity (USD) | -1.39B |
| Assets Non-Current | 421.63M |
| Total Debt (USD) | 24.79M |
| Deferred Revenue | 18.05M |
| Liabilities Non-Current | 60.73M |
| Trade and Non-Trade Payables | 14.34M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 451.00K |
| Net Cash Flow from Financing | -1.05M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -234.34M |
| Capital Expenditure | -14.20M |
| Net Cash Flow from Investing | -166.01M |
| Net Cash Flow - Investment Acquisitions and Disposals | -151.81M |
| Net Cash Flow from Operations | -67.25M |
| Effect of Exchange Rate Changes on Cash | -35.00K |
| Share Based Compensation | 4.26M |